Synthesis and characterization of cationic contrast agents & imaging of articular cartilage using X-ray computed tomography and magnetic resonance
Please note: we were unable to immediately open the spreadsheet below. We repaired the spreadsheet file with Excel, and have a copy of it in storage. If you have difficulty opening the spreadsheet, please write to us at open-help@bu.edu. === Osteoarthritis (OA) is a painful, chronic, non-inflammator...
Main Author: | |
---|---|
Language: | en_US |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/13986 |
id |
ndltd-bu.edu-oai-open.bu.edu-2144-13986 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-bu.edu-oai-open.bu.edu-2144-139862020-07-29T17:00:50Z Synthesis and characterization of cationic contrast agents & imaging of articular cartilage using X-ray computed tomography and magnetic resonance Freedman, Jonathan David Pharmacology Glycosaminoglycans Articular cartilage Computed tomography Contrast agents Magnetic resonance imaging Please note: we were unable to immediately open the spreadsheet below. We repaired the spreadsheet file with Excel, and have a copy of it in storage. If you have difficulty opening the spreadsheet, please write to us at open-help@bu.edu. Osteoarthritis (OA) is a painful, chronic, non-inflammatory disease affecting 140 million people worldwide that alters synovial joint structure and function. OA progressively breaks down hyaline cartilage, the hydrated tissue that provides a smooth, nearly frictionless surface and distributes loads applied to articulating joint surfaces. The loss of glycosaminoglycans (GAGs) from the extracellular matrix of cartilage is an early marker of OA. Therefore, imaging methods that quantify the GAG content of cartilage are of interest. This work investigates the synthesis and development of three cationic contrast agents (CAs) for imaging articular cartilage (AC): CA4+, an iodinated small molecule, and tantalum oxide nanoparticles (Ta2O5 NPs) for x-ray Computed Tomography (CT) imaging; and Gadopentetate-dilysine (Gd(DTPA)Lys2), a gadolinium small molecule for Magnetic Resonance (MR) imaging. These cationic contrast agents are attracted to the strong negative fixed charge of extracellular GAG and, therefore, infiltrate cartilage. This work begins with an overview of CT and MR imaging basic principles, current clinical CAs and contrast enhanced imaging of AC. First, the large-scale (50 g) synthesis of CA4+ is described and the partitioning over time of CA4+ into ex vivo AC is correlated to GAG content and cartilage mechanical properties. Similar partitioning studies are applied to anionic, neutral and cationic Ta2O5 NPs, where the cationic NP exhibited substantially greater affinity for AC. Moreover, by maintaining the positive charge on the NP surface and introducing a polyethylene glycol coating, a NP formulation is described for successful in vivo cartilage imaging. Next described is the MRI CA, Gd(DTPA)Lys2, which affords an equivalent T1 signal in cartilage at 1/10th the effective dosage of anionic gadopentetate. Finally, the equilibrium partitioning of the small molecule CT and MRI CAs is directly compared to GAG content and mechanical properties in human finger AC. In summary, results show cationic CAs strongly correlate to both GAG and mechanical properties and distribute in direct proportion to GAG unlike anionic CAs. The use of cationic CAs to quantify the biochemical and mechanical changes of AC may aid drug discovery and improve clinical assessment and intervention of OA for future patients. 2017-11-03T00:00:00Z 2016-01-12T16:50:24Z 2015 2015-11-03T20:11:06Z Thesis/Dissertation https://hdl.handle.net/2144/13986 en_US |
collection |
NDLTD |
language |
en_US |
sources |
NDLTD |
topic |
Pharmacology Glycosaminoglycans Articular cartilage Computed tomography Contrast agents Magnetic resonance imaging |
spellingShingle |
Pharmacology Glycosaminoglycans Articular cartilage Computed tomography Contrast agents Magnetic resonance imaging Freedman, Jonathan David Synthesis and characterization of cationic contrast agents & imaging of articular cartilage using X-ray computed tomography and magnetic resonance |
description |
Please note: we were unable to immediately open the spreadsheet below. We repaired the spreadsheet file with Excel, and have a copy of it in storage. If you have difficulty opening the spreadsheet, please write to us at open-help@bu.edu. === Osteoarthritis (OA) is a painful, chronic, non-inflammatory disease affecting 140 million people worldwide that alters synovial joint structure and function. OA progressively breaks down hyaline cartilage, the hydrated tissue that provides a smooth, nearly frictionless surface and distributes loads applied to articulating joint surfaces. The loss of glycosaminoglycans (GAGs) from the extracellular matrix of cartilage is an early marker of OA. Therefore, imaging methods that quantify the GAG content of cartilage are of interest. This work investigates the synthesis and development of three cationic contrast agents (CAs) for imaging articular cartilage (AC): CA4+, an iodinated small molecule, and tantalum oxide nanoparticles (Ta2O5 NPs) for x-ray Computed Tomography (CT) imaging; and Gadopentetate-dilysine (Gd(DTPA)Lys2), a gadolinium small molecule for Magnetic Resonance (MR) imaging. These cationic contrast agents are attracted to the strong negative fixed charge of extracellular GAG and, therefore, infiltrate cartilage.
This work begins with an overview of CT and MR imaging basic principles, current clinical CAs and contrast enhanced imaging of AC. First, the large-scale (50 g) synthesis of CA4+ is described and the partitioning over time of CA4+ into ex vivo AC is correlated to GAG content and cartilage mechanical properties. Similar partitioning studies are applied to anionic, neutral and cationic Ta2O5 NPs, where the cationic NP exhibited substantially greater affinity for AC. Moreover, by maintaining the positive charge on the NP surface and introducing a polyethylene glycol coating, a NP formulation is described for successful in vivo cartilage imaging. Next described is the MRI CA, Gd(DTPA)Lys2, which affords an equivalent T1 signal in cartilage at 1/10th the effective dosage of anionic gadopentetate. Finally, the equilibrium partitioning of the small molecule CT and MRI CAs is directly compared to GAG content and mechanical properties in human finger AC.
In summary, results show cationic CAs strongly correlate to both GAG and mechanical properties and distribute in direct proportion to GAG unlike anionic CAs. The use of cationic CAs to quantify the biochemical and mechanical changes of AC may aid drug discovery and improve clinical assessment and intervention of OA for future patients. === 2017-11-03T00:00:00Z |
author |
Freedman, Jonathan David |
author_facet |
Freedman, Jonathan David |
author_sort |
Freedman, Jonathan David |
title |
Synthesis and characterization of cationic contrast agents & imaging of articular cartilage using X-ray computed tomography and magnetic resonance |
title_short |
Synthesis and characterization of cationic contrast agents & imaging of articular cartilage using X-ray computed tomography and magnetic resonance |
title_full |
Synthesis and characterization of cationic contrast agents & imaging of articular cartilage using X-ray computed tomography and magnetic resonance |
title_fullStr |
Synthesis and characterization of cationic contrast agents & imaging of articular cartilage using X-ray computed tomography and magnetic resonance |
title_full_unstemmed |
Synthesis and characterization of cationic contrast agents & imaging of articular cartilage using X-ray computed tomography and magnetic resonance |
title_sort |
synthesis and characterization of cationic contrast agents & imaging of articular cartilage using x-ray computed tomography and magnetic resonance |
publishDate |
2016 |
url |
https://hdl.handle.net/2144/13986 |
work_keys_str_mv |
AT freedmanjonathandavid synthesisandcharacterizationofcationiccontrastagentsimagingofarticularcartilageusingxraycomputedtomographyandmagneticresonance |
_version_ |
1719333772077301760 |